News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Study Shows Aspirin Can Help Prevent Dangerous Blood Clots


Website www.hrc.govt.nz

7 November 2012

Study Shows Aspirin Can Help Prevent Dangerous Blood Clots

Media Release

An international study, part-funded by the Health Research Council of New Zealand (HRC), shows low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the veins of the leg or in the lungs.

The study, which has just been published in The New England Journal of Medicine, found people with blood clots in the veins of the leg (deep vein thrombosis or DVT) or the lungs (pulmonary embolism or PE), also known as venous thromboembolism (VTE) are less likely to suffer a recurrence of the serious blood clots or a cardiac event if they take low-dose aspirin.

Running since 2003, the ASPIRE study completed recruitment of 822 participants from five countries including Australia, New Zealand, Singapore, India and Argentina. More than a quarter of the patients were recruited in New Zealand, with funding for the New Zealand investigators provided by a $537,000 grant from the Health Research Council of New Zealand.

All the participants previously had DVT or PE that occurred for no particular reason, and had completed on average six months of anticoagulant treatment (generally with warfarin). Participants were randomly allocated to receive either low dose enteric coated aspirin 100mg daily or a matching placebo. On average, participants were followed for three years.

Blood clots in the veins of the leg or the lungs are a common condition and affect about 1 in every 1000 persons in New Zealand and Australia each year.

Dr Tim Brighton, a haematologist in Sydney and principal investigator of the study, said many patients discontinue warfarin therapy after 6 or 12 months of treatment due to the inconvenience of regular blood tests and the increased risks of serious bleeding. However, if warfarin therapy is stopped these patients are at high risk of recurring thrombosis.

“The ASPIRE study found that aspirin reduces the risk of important blood clotting events, including recurrent VTE, myocardial infarction, stroke, or cardiovascular death. We now

have clear evidence that aspirin is of benefit for patients who are unable or do not wish to continue warfarin in the long term.”

Director of the Thrombosis Unit at Auckland Hospital, Dr Paul Ockelford, who led the New Zealand trials, says: “The results of this study will change our practice managing patients with venous thromboembolism, so it’s an exciting development. Unless a patient is a candidate for extended anticoagulants, we now have the evidence to recommend long-term aspirin as it’s not only effective, but also safe and cheap.”

Collaboration

o The study was conducted by NHMRC Clinical Trials Centre at the University of Sydney and investigators in Australia, New Zealand, India, Singapore and Argentina.

o The study was supported by project grants from Australia’s National Health and Medical Research Council, the Health Research Council of New Zealand, the Australasian Society of Thrombosis and Haemostasis, and Bayer HealthCare, Germany. Aspirin and matching placebo were provided without charge by Bayer HealthCare Pharmaceuticals who played no other role in the study.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

With Hunters & Collectors: The Rolling Stones Announce New Auckland Date

It’s the news New Zealand has been waiting for. The Rolling Stones today confirmed the rescheduled dates and venues for both the Australian and New Zealand legs of their highly anticipated ’14 On Fire’ tour. Now, Frontier Touring is also delighted ... More>>

ALSO:

Flying Things: Conchords, Pretties Help BATS Fly Home

The launch of BATS theatre’s fundraising campaign has taken off – with a bit of help from their friends. And with friends like theirs… An event last night hosted by Te Radar at Wellington’s latest waterfront venue, Shed 6, featured Fly My Pretties and, in a dream-come-true scenario, Flight of the Conchords. More>>

ALSO:

Environment: Zoo’s Own Wētā Workshop Produces Rare Giants For Release

Following unprecedented breeding and rearing success, Auckland Zoo is today releasing 150 of New Zealand’s largest giant wētā, the wētā punga, onto pest-free Motuora Island in the Hauraki Gulf. A further 150 will be released onto Tiritiri Matangi next month. More>>

Girls On Film: Divergent Hits The Big Screen

n January, Catching Fire (the second film in the Hunger Games series) not only became the biggest US box office success of 2013 : it also became the first film starring a female actor (ie. Jennifer Lawrence) to top the annual domestic earnings chart since The Exorcist, 40 years ago. More>>

ALSO:

Wellington.Scoop: No Travel Sanctions For Russian Billionaire’s Superyacht

On the same day that New Zealand announced travel sanctions against selected Russians, a Russian billionaire’s superyacht berthed in Wellington Harbour. More>>

ALSO:

Mental Health: UC Researchers Believe Robots Can Persuade People To Conform

A team of University of Canterbury (UC) researchers and scientists believe robots can persuade people to conform through group pressure... ``Our results showed that robots can induce conformity but to a significantly lesser degree than humans." More>>

NZ On Air: Local Content Holds Steady At 32% Of Television Schedules

Since 1989 NZ On Air has measured local free-to-air television content. The report compares the schedules of the six national free-to-air channels, to observe trends and changes in the local content landscape. More>>

Arts Fest: 2014 New Zealand Festival A Spectacular Celebration

The New Zealand Festival welcomed the world to Wellington over 24 days (21 Feb – 16 Mar) of arts events across the city. “[current figures show] slight increase on the 110,000 tickets issued in 2012. It’s a great result.” More>>

Opera: Happy 70th Birthday Dame Kiri Te Kanawa

Our first lady of song who “feels more like at 15 year old” will celebrate her significant birthday on stage at Covent Garden tomorrow night (Friday morning NZT), performing in the Royal Opera House’s production of La fille du régiment (The Daughter of the Regiment) as La Duchess de Crackentorp. More>>

ALSO:

Get More From Scoop

 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news